Computed tomographic colonography (CTC) without bowel preparation correctly identified more than 90% of adenomas ≥10 mm in a recent multicenter study. Key Point: Laxative-free colonography is accurate at detecting adenomas 10 mm and larger but is less reliable for detecting smaller lesions. Most polyps that affect survival are 10 mm…
Read more »
While reducing the risk of classic fracture, treatment with bisphosphonates may increase the risk of atypical fractures of the femur, with a longer duration of treatment linked to this increasing risk, according to a new study. “We have demonstrated that the association between bisphosphonate treatment and the occurrence of atypical…
Read more »
Patients with chronic kidney disease (CKD) have an increased risk of myocardial infarction (MI) and a higher MI mortality rate as compared with patients diagnosed with diabetes or who have had a prior MI event, according to a recently published study. “Chronic kidney disease in India is a public health…
Read more »
A daily resveratrol supplement used for 3 months improved glycemic control in a small study of Indian patients with type 2 diabetes who were already taking oral hypoglycemic agents, found researchers from the JSS College of Pharmacy in Tamilnadu, India. Key Point: Oral supplementation of resveratrol improves glycemic control and…
Read more »
Cardiovascular disease has emerged as the number one killer in both urban and rural areas of India. The Indian population is particularly susceptible to cardiovascular disease (CVD) risk factors; however, there are few large studies that have examined CVD risk factors in the Indian population. Depression is associated with an…
Read more »
Even patients with a 5-year risk for major vascular events <10% may benefit from primary prevention using statin therapy, according to the results of a large meta-analysis. This study may hold particular significance for patients in India, where genetic susceptibility results in a higher rate of vascular events, and where…
Read more »
indicates a Peer-Reviewed Article
Beta blockers and cardiac resynchronization show greatest survival benefit for patients with heart failure
Data on the comparative merits of drugs recommended to manage heart failure (HF) are limited. A recent case-control study compared HF patients who died within 24 months of diagnosis with those who survived to 24 months after a HF diagnosis. The researchers compared the 2 groups to see which therapies…
Read more »